Souleymane Dama

Pyronaridine–artesunate or dihydroartemisinin–piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial

Issaka Sagara, Abdoul Habib Béavogui, Issaka Zongo et al. · The Lancet · 2018 · 133 citations · Full text

Efficacy, Safety, and Selection of Molecular Markers of Drug Resistance by Two ACTs in Mali

Abdoulaye Djimdé, Bakary Fofana, Issaka Sagara et al. · American Journal of Tropical Medicine and Hygiene · 2008 · 85 citations · Full text

No Evidence of Delayed Parasite Clearance after Oral Artesunate Treatment of Uncomplicated Falciparum Malaria in Mali

Amelia W. Maiga, Bakary Fofana, Issaka Sagara et al. · American Journal of Tropical Medicine and Hygiene · 2012 · 68 citations · Full text

Molecular markers of resistance to sulphadoxine-pyrimethamine one year after implementation of intermittent preventive treatment of malaria in infants in Mali

Alassane Dicko, Issaka Sagara, Abdoulaye Djimdé et al. · Malaria Journal · 2010 · 52 citations · Full text

Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali

Mamadou Teketé, Abdoulaye Djimdé, Abdoul Habib Béavogui et al. · Malaria Journal · 2009 · 41 citations · Full text